Erectile Dysfunction (ED) Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028
Report Highlights
Erectile Dysfunction (ED) Drugs Market – Scope of Report
TMR’s report on the global erectile dysfunction (ED) drugs market studies the past as well as current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2021 to 2028. The report provides revenue of the global erectile dysfunction (ED) drugs market for the period 2020–2028, considering 2020 as the base year and 2021 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the global erectile dysfunction (ED) drugs market during the forecast period.
The report has been prepared after an extensive primary and secondary research. Primary research involved bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers. Extensive secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global erectile dysfunction (ED) drugs market.
Secondary research also included Internet sources, statistical data from government agencies, websites, company presentations, sales data, and trade associations. Analysts have employed a combination of top-down and bottom-up approaches to study various phenomenon in the global erectile dysfunction (ED) drugs market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Furthermore, the report sheds light on the changing competitive dynamics in the global erectile dysfunction (ED) drugs market. These indices serve as valuable tools for existing market players as well as for entities interested in entering the global erectile dysfunction (ED) drugs market.
The report delves into the competition landscape of the global erectile dysfunction (ED) drugs market. Key players operating in the global erectile dysfunction (ED) drugs market have been identified, and each one of these has been profiled for distinguishing business attributes. Company overview, financial standings, recent developments, and SWOT are some of the attributes of players in the global erectile dysfunction (ED) drugs market that have been profiled in this report.
Key Questions Answered in Erectile Dysfunction (ED) Drugs Market Report
- What is the scope of growth of product companies in the global erectile dysfunction (ED) drugs market?
- What will be the Y-o-Y growth of the global erectile dysfunction (ED) drugs market between 2020 and 2028?
- What is the influence of changing trends in technologies on the global erectile dysfunction (ED) drugs market?
- Will North America be the most profitable market for medical device technology providers?
- Which factors are anticipated to hamper the growth of the global erectile dysfunction (ED) drugs market during the forecast period?
- Which are the leading companies in the global erectile dysfunction (ED) drugs market?
Research Methodology
A unique research methodology has been utilized by TMR to conduct comprehensive research on the growth of the global erectile dysfunction (ED) drugs market and arrive at conclusions on its growth prospects. This research methodology is a combination of primary and secondary research, which helps analysts warrant the accuracy and reliability of the drawn conclusions.
Secondary methods referred to by analysts during the production of the global erectile dysfunction (ED) drugs market report include statistics from company annual reports, SEC filings, company websites, investor presentations, regulatory databases, government publications, and industry white papers. Analysts have also interviewed senior managers, product portfolio managers, CEOs, VPs, and market intelligence managers, who contributed to the production of TMR’s study on the erectile dysfunction (ED) drugs market as primary methods.
These primary and secondary methods have provided exclusive information during interviews, which serves as a validation from the erectile dysfunction (ED) drugs market leaders. Access to an extensive internal repository and external proprietary databases enabled this report to address specific details and questions about the global erectile dysfunction (ED) drugs market with accuracy. The study also uses the top-down approach to assess the revenue for each segment and the bottom-up approach to counter-validate them. This has helped in reaching TMR’s estimates on future prospects of the global erectile dysfunction (ED) drugs market more reliably and accurately.
- Table 1 : Global Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2018–2028
- Table 2 : Global Erectile Dysfunction (ED) Drug Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2028
- Table 3 : Global Erectile Dysfunction (ED) Drug Market Size (US$ Mn) Forecast, by Region, 2018–2028
- Table 4 : North America Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Country, 2018–2028
- Table 5 : North America Erectile Dysfunction (ED) Drug Market Size (US$ Mn) Forecast, by Drug Class, 2018–2028
- Table 6 : North America Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2028
- Table 7 : Europe Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
- Table 8 : Europe Erectile Dysfunction (ED) Drug Market Size (US$ Mn) Forecast, by Drug Class, 2018–2028
- Table 9 : Europe Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2028
- Table 10 : Asia Pacific Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
- Table 11 : Asia Pacific Erectile Dysfunction (ED) Drug Market Size (US$ Mn) Forecast, by Drug Class, 2018–2028
- Table 12 : Asia Pacific Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2028
- Table 13 : Middle East & Africa Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
- Table 14 : Middle East & Africa Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2018–2028
- Table 15 : Middle East & Africa Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2028
- Table 16 : Latin America Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2018–2028
- Table 17 : Latin America Erectile Dysfunction (ED) Drug Market Size (US$ Mn) Forecast, by Drug Class, 2018–2028
- Table 18 : Latin America Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2018–2028
- Table 19 : Pfizer, Inc. Products Offered
- Table 20 : Pfizer, Inc. Recent Developments
- Table 21 : Dong-A ST Co., Ltd. Products Offered
- Table 22 : Dong-A ST Co., Ltd. Recent Developments
- Table 23 : Eli Lilly and Company Products Offered
- Table 24 : Eli Lilly and Company Recent Developments
- Table 25 : Bayer AG Products Offered
- Table 26 : Bayer AG Recent Developments
- Table 27 : VIVUS, INC. Ltd. Products Offered
- Table 28 : VIVUS, INC. Recent Developments
- Table 29 : SK chemicals Products Offered
- Table 30 : SK chemicals Recent Developments
- Table 31 : Meda Pharmaceuticals Inc. Products Offered
- Table 32 : Meda Pharmaceuticals Inc. Recent Developments
- Table 33 : Cristalia Produtos Quimicos Farmaceuticos Ltda. Products Offered
- Table 34 : Cristalia Produtos Quimicos Farmaceuticos Ltda. Recent Developments
- Table 35 : Apricus Biosciences, Inc. Products Offered
- Table 36 : Apricus Biosciences, Inc. Recent Developments
- Table 37 : Teva Pharmaceutical Industries Ltd. Products Offered
- Figure 1 : Global Erectile Dysfunction (ED) Drug Market Size (US$ Mn) Forecast, 2020–2028
- Figure 2 : Market Value Share, by Drug Class (2020)
- Figure 3 : Market Value Share, by Distribution Channel (2020)
- Figure 4 : Market Value Share, by Region (2020)
- Figure 5 : Global Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Drug, 2020 and 2028
- Figure 6 : Global Erectile Dysfunction (ED) Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Viagra, 2020–2028
- Figure 7 : Global Erectile Dysfunction (ED) Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Cialis, 2020–2028
- Figure 8 : Global Erectile Dysfunction (ED) Drug Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Staxyn/Levitra, 2020–2028
- Figure 9 : Global Erectile Dysfunction (ED) Drug Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Stendra/Spedra, 2020–2028
- Figure 10 : Global Erectile Dysfunction (ED) Drug Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by others, 2020–2028
- Figure 11 : Global Erectile Dysfunction (ED) Drug Market Value Share Analysis, by Distribution channel, 2020 and 2028
- Figure 12 : Global Erectile Dysfunction (ED) Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Hospital Pharmacies, 2020–2028
- Figure 13 : Global Erectile Dysfunction (ED) Drugs Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Retail Pharmacies, 2020–2028
- Figure 14 : Global Erectile Dysfunction (ED) Drug Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), by Online Pharmacies, 2020-2028
- Figure 15 : Global Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Region, 2020 and 2028
- Figure 16 : North America Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2020–2028
- Figure 17 : North America Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Country, 2020 and 2028
- Figure 18 : North America Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Drug, 2020 and 2028
- Figure 19 : North America Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Distribution Channel, 2020 and 2028
- Figure 20 : Europe Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2028
- Figure 21 : Europe Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
- Figure 22 : Europe Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Drug, 2020 and 2028
- Figure 23 : Europe Erectile Dysfunction (ED) Drugs Treatment Market Value Share Analysis, by Distribution Channel, 2020 and 2028
- Figure 24 : Asia Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2028
- Figure 25 : Asia Pacific Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
- Figure 26 : Asia Pacific Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Drug Class, 2020 and 2028
- Figure 27 : Asia Pacific Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Distribution Channel, 2020 and 2028
- Figure 28 : Middle East & Africa Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2028
- Figure 29 : Middle East & Africa Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
- Figure 30 : Middle East & Africa Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Drug Class, 2020 and 2028
- Figure 31 : Middle East & Africa Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Distribution Channel, 2020 and 2028
- Figure 32 : Latin America Erectile Dysfunction (ED) Drugs Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2028
- Figure 33 : Latin America Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Country/Sub-region, 2020 and 2028
- Figure 34 : Latin America Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Drug, 2020 and 2028
- Figure 35 : Latin America Erectile Dysfunction (ED) Drugs Market Value Share Analysis, by Distribution Channel, 2020 and 2028
- Figure 36 : Global Erectile Dysfunction (ED) Drugs Market Share Analysis, by Company (2020)
- Figure 37 : Pfizer, Inc. Breakdown of Net Sales, by Region, 2020
- Figure 38 : Pfizer, Inc. Revenue (US$ Bn) and Y-o-Y Growth (%), 2018–2020
- Figure 39 : Pfizer, Inc. R&D Intensity and Sales & Marketing Intensity – Company Level, 2018–2028
- Figure 40 : Dong-A ST Co., Ltd. Breakdown of Net Sales, by Businesses Segment
- Figure 41 : Dong-A ST Co., Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2018–2020
- Figure 42 : Dong-A ST Co., Ltd. R&D Intensity and Sales & Marketing Intensity – Company Level, 2018–2028
- Figure 43 : Eli Lilly and Company Revenue (US$ Bn) & Y-o-Y Growth (%), 2018–2020
- Figure 44 : Eli Lilly and Company R&D Intensity and Sales & Marketing Intensity – Company Level, 2018–2028
- Figure 45 : Eli Lilly and Company Breakdown of Net Sales, by Region (Company Level), 2020
- Figure 46 : Eli Lilly and Company Breakdown of Net Sales, (by Endocrinology Level), 2020
- Figure 47 : Bayer AG Breakdown of Net Sales, by Region, 2020
- Figure 48 : Bayer AG Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020
- Figure 49 : Bayer AG R&D Intensity and Net Income (US$ Mn) – Company Level, 2020
- Figure 50 : VIVUS, INC. R&D Intensity and Sales & Marketing Intensity – Company Level, 2018–2028
- Figure 51 : VIVUS, INC. Breakdown of Revenue, by Operation (Company Level), 2020
- Figure 52 : VIVUS, INC. Breakdown of Research and Development Expenses, 2020
- Figure 53 : SK chemicals Consolidated Balance Sheet (US$ Bn), 2020
- Figure 54 : SK chemicals Revenue (US$ Bn) and Y-o-Y Growth (%), 2018–2020
- Figure 55 : SK chemicals R&D Intensity and Net Income (US$ Mn) – Company Level, 2018–2020
- Figure 56 : Meda Pharmaceuticals Inc. Breakdown of Net Sales, by Region, 2020
- Figure 57 : Meda Pharmaceuticals Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018-2020
- Figure 58 : Meda Pharmaceuticals Inc. Selling, Medicine &business development and administrative expenses (US$ Mn) – Company Level, 2018-2020
- Figure 59 : Apricus Biosciences, Inc. Breakdown of Net Sales, by Region, 2020
- Figure 60 : Apricus Biosciences, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2018–2020
- Figure 61 : Apricus Biosciences, Inc. R&D and General & administrative (US$ Mn) – Company Level, 2018–2028
- Figure 62 : Teva Pharmaceutical Industries Ltd. Revenue (US$ Bn) & Y-o-Y Growth (%), 2018–2020
- Figure 63 : Teva Pharmaceutical Industries Ltd. R&D Intensity and Sales & Marketing Intensity (%) – Company Level, 2018–2028
- Figure 64 : Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales, by Region 2020
- Figure 65 : Teva Pharmaceutical Industries Ltd. Breakdown of Net Sales, (Overall Company Level), 2020
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.
Similar Reports from Transparency
Erectile Dysfunction (ED) Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026
Erectile Dysfunction (ED) Drugs Market - Overview
This report studies the current as well as future prospects of the global erectile dysfunction (ED) drugs market. Stakeholders of the market include companies and intermediaries engaged in the manufacture, commercialization, and marketing of therapeutic drugs for the treatment of erectile dysfunction, as well as new players planning to enter the market. The ...